Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group-Reference-Cited by-同舟云学术

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

Published:2009-02-03 Issue:5 Volume:64 Page:893-899
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Comella Pasquale,Lorusso Vito,Maiorino Luigi,Casaretti Rossana,Cannone Michele,Massidda Bruno,Putzu Carlo,Leo Silvana,Roselli Mario,Mancarella Sergio,Palmeri Sergio,Greco Ettore,Vessia Giacomo,Sandomenico Claudia,Franco Luca

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-0938-4.pdf

Reference37 articles.

1. Wohrer SS, Radere M, Hejna M (2004) Palliative chemotherapy for advanced gastric cancer. Ann Oncol 15:1585–1595

2. Van Cutsem E, Van de Velde C, Roth A et al (2008) Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)—Gastrointestinal Cancer Group. Eur J Cancer 44:182–194

3. Wagner AD, Grothe W, Haerting J et al (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24:2903–2909

4. Cunningham C, Jost LM, Purkalne G, Oliveira J (2005) ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of gastric cancer. Ann Oncol 16:22–23

5. Webb A, Cunningham D, Scarffe JH et al (1997) Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15:261–267

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy;Trials;2023-01-20

2. Gastric cancer: Russian clinical guidelines;Journal of Modern Oncology;2021-12-15

3. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs;Medicine;2020-12-11

4. Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population;Pan African Medical Journal;2020-03-19

5. Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin;Supportive Care in Cancer;2020-01-23